Over 70% of the US population is either obese or overweight. With that being said, Type 2 diabetes, heart disease, peripheral vascular disease, cancer treated with chemotherapy, and metabolic conditions are not going anywhere anytime soon. One of the main symptoms with all of these is peripheral neuropathy. Neuropathy is a condition that baby boomers and even younger adults now struggle with and there is virtually no medical solution out there other than pain relieving medications. Most of these medications are used as off label and are dangerous to take long term.
With our neuropathy niche clinical business model you are able to streamline your acquisition process through automation, allowing you to work on the business and not in it. Our hybrid at-home/in-clinic program is designed for the patient to have the ability to treat themselves 75% at home, be educated from home, while coming into the office minimally, getting better clinical results with research-backed technologies.
The antiquated neuropathy model of coming in the office multiple times only puts strain on your staff, your time, your energy, your schedule and the patient.
By using our hybrid model and practice automation strategies you will be able to combine neuropathy with other niches when presented like gut health, weight loss, knee pain, spinal degenerative conditions and more. This will allow you to offer better clinical programs, collect more money, all while working less.